Therapeutic effects of rifampin and erythromycin in experimental murine brucellosis

dc.contributor.authorFelek, S
dc.contributor.authorDemirdag, K
dc.contributor.authorKalkan, A
dc.contributor.authorAkbulut, A
dc.date.accessioned2026-08-12T17:41:48Z
dc.date.issued2000
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.1046/j.1469-0691.2000.00016-4.x
dc.identifier.endpage114
dc.identifier.issn1198-743X
dc.identifier.issue2
dc.identifier.pmid11168083
dc.identifier.scopus2-s2.0-0347740256
dc.identifier.scopusqualityQ1
dc.identifier.startpage111
dc.identifier.urihttps://doi.org/10.1046/j.1469-0691.2000.00016-4.x
dc.identifier.urihttps://hdl.handle.net/11508/59473
dc.identifier.volume6
dc.identifier.wosWOS:000086861100011
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBlackwell Science Ltd
dc.relation.ispartofClinical Microbiology and Infection
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectDoxycycline
dc.subjectAzithromycin
dc.subjectEfficacy
dc.titleTherapeutic effects of rifampin and erythromycin in experimental murine brucellosis
dc.typeArticle

Dosyalar